T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Stem
STEM
$55.9M
| $185K | ﹤0.01% |
8,307
+402
| +5% | +$11.8K |
|
2602
UroGen Pharma
URGN
$2.34B
| $184K | ﹤0.01% |
10,948
-256,195
| -96% | -$3.64M |
|
2603
Quad
QUAD
$506M
| $183K | ﹤0.01% |
33,554
+527
| +2% | +$2.59K |
|
|
TERN
2604
DELISTED
Terns Pharmaceuticals
TERN
| $182K | ﹤0.01% |
26,683
+5,989
| +29% | +$36.3K |
|
2605
Telos
TLS
$344M
| $182K | ﹤0.01% |
45,042
+18,036
| +67% | +$68.5K |
|
2606
Varex Imaging
VREX
$780M
| $182K | ﹤0.01% |
12,328
+946
| +8% | +$15.1K |
|
2607
Paysafe
PSFE
$405M
| $180K | ﹤0.01% |
+10,151
| New | +$169K |
|
2608
DocGo
DCGO
$64.5M
| $177K | ﹤0.01% |
57,028
+9,812
| +21% | +$32.3K |
|
|
LGF.A
2609
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $177K | ﹤0.01% |
18,759
+2,071
| +12% | +$20K |
|
2610
Hyliion Holdings
HYLN
$734M
| $176K | ﹤0.01% |
108,146
+4,060
| +4% | +$6.03K |
|
2611
KVH Industries
KVHI
$143M
| $176K | ﹤0.01% |
37,763
-4,622
| -11% | -$23.1K |
|
2612
Designer Brands
DBI
$312M
| $175K | ﹤0.01% |
25,519
+743
| +3% | +$6.57K |
|
2613
Cadiz
CDZI
$295M
| $171K | ﹤0.01% |
55,305
| – | – |
|
2614
Century Casinos
CNTY
$35.2M
| $171K | ﹤0.01% |
61,400
-6,464
| -10% | -$18.8K |
|
2615
TTEC Holdings
TTEC
$77.4M
| $171K | ﹤0.01% |
28,919
+5,300
| +22% | +$38.8K |
|
2616
Genie Energy
GNE
$386M
| $170K | ﹤0.01% |
11,582
-1,777
| -13% | -$27K |
|
2617
Horizon Bancorp
HBNC
$1.05B
| $170K | ﹤0.01% |
13,713
+1,366
| +11% | +$16.4K |
|
|
KREF
2618
KKR Real Estate Finance Trust
KREF
$502M
| $169K | ﹤0.01% |
18,613
+1,767
| +10% | +$16.9K |
|
2619
RPC Inc
RES
$1.39B
| $169K | ﹤0.01% |
26,994
+2,601
| +11% | +$18.2K |
|
2620
Cricut
CRCT
$1.24B
| $168K | ﹤0.01% |
28,008
| – | – |
|
2621
Portillo's
PTLO
$365M
| $168K | ﹤0.01% |
17,221
+4,258
| +33% | +$47.4K |
|
2622
Inovio Pharmaceuticals
INO
$93M
| $167K | ﹤0.01% |
20,652
+8,153
| +65% | +$85.8K |
|
2623
TaskUs
TASK
$667M
| $167K | ﹤0.01% |
12,500
+2,300
| +23% | +$29.6K |
|
2624
Accuray
ARAY
$32.9M
| $166K | ﹤0.01% |
91,146
+18,000
| +25% | +$34.3K |
|
|
MCHB
2625
Mechanics Bancorp
MCHB
$3.79B
| $165K | ﹤0.01% |
14,467
+21
| +0.1% | +$230 |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.